Inso Biosciences Inc.

Biotech Ithaca, NY

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Ithaca, NY
Street
237 Tower Road, Room 410
Zip
14853

Offering

Total offering
$3M
Amount sold
$750k
First sale
Mar 3, 2026
Min investment
$0
Securities
Debt, Other
Federal exemption
Rule 506(b)
Investors so far
9

How this filing compares

Ranked #22 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 1.0× the median.

Other New York filings this week: 1791 Capital Partners Evergreen Fund, LP, 1791 Capital Partners, LP, 2E Select Credit Onshore Fund, LP, AG Kai Bo Realty, L.P., ALGER DYNAMIC RETURN FUND LLC

Leadership

Harvey Chen Tian — Executive Officer (also: Director)

Adam Bisogni — Director

Filing details

Inso Biosciences Inc. filed a Form D with the SEC on April 10, 2026.

Other newest Biotech companies

Other newest companies in New York